Search results for

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Yaccarino, a traditional business executive, was in many ways a strong foil to the mercurial and controversy-courting Musk. She did not cite a reason for her departure.

President Trump kicked off his second term with a dramatic crackdown on immigration. Critics call those moves cruel and unnecessary. But many of Trump's supporters are applauding these early steps.

The scope of DOGE's work and the identities of the people carrying it out isn't fully clear — leaving agencies and government workers in chaos.

A new analysis shows that health insurance premiums for Obamacare are set to soar next year, as financial help that subsidized the cost expires. Congress is not likely to extend the subsidies.

A federal district judge issued a temporary restraining order after the U.S. attempted to deport hundreds of unaccompanied Guatemalan children without proper immigration proceedings.

Creatine supplements have long become increasingly popular as social media influencers tout their benefits. What does the evidence say?

More than 250 news outlets around the world have signed onto an appeal that calls for the protection of Palestinian journalists in Gaza, and for press to have independent access to the territory.

The president of the American Bar Association says that the Trump administration is targeting judges and lawyers who make decisions it disagrees with.

Poets Hanif Abdurraqib, Franny Choi, Dan "Sully" Sullivan, and club founder Peter Kahn have curated a new anthology celebrating the legacy of a Chicago-area high school's spoken word club.